manufacturing & consulting
Pharmaceutical, Biotechnology & Medical Device Industries
Message: Announces Corporate Changes
| April 13, 2009 |
| PharmEng Announces Corporate Changes |
| TORONTO, ONTARIO--(Marketwire - April 13, 2009) - PharmEng International Inc. (the "Company") (TSX VENTURE:PII) today announced as part of its ongoing efforts to restructure the Company that it has decided to reduce corporate costs. Effectively immediately, the CEO took a 50% salary reduction and the Company's CFO Brian Fielding, Vice-President of Marketing John Durham and Vice-President Charles Ivey have left the Company. In addition to reducing the size of its management team, the Company announces that Bernard Boudreau, Edgar Parker, Aditya Jah, Vasu Chanchlani and Michael Sefton have all resigned from the board of directors of the Company effective immediately. The Company would like to sincerely thank all of the departing members of management and the board of directors for their service and dedication to the Company over the past years. About PharmEng International Inc. PharmEng International Inc., headquartered in Toronto, Canada, is a full-service consulting and contract manufacturing company that serves the pharmaceutical and biotechnology industries in North America and internationally. Consulting services include project management, engineering, GMP, validation, calibration, regulatory compliance and certified training. Contract manufacturing includes pharmaceutical support, formulation development, laboratory testing, and finished solid dosage and liquid products. PharmEng's shares trade on the TSX Venture Exchange under the symbol PII. For more information about PharmEng, please visit the Company's website at www.pharmeng.com. |
Loading...
Loading...
New Message
Please
login
to post a reply